Bausch Health Enters New Shareholder Agreements with Icahn, Paulson, and Kavanagh Groups to Strengthen Board Oversight

Reuters
05-21
Bausch Health Enters New Shareholder Agreements with Icahn, Paulson, and Kavanagh Groups to Strengthen Board Oversight

Bausch Health Companies Inc. has announced new shareholder agreements with major investor groups, including the Icahn Group, the Paulson Group, and the Kavanagh Group, as of May 20, 2025. These agreements dictate that if any group engages in a "Specified Action," such as initiating a proxy contest against the company, they must resign from the boards of both Bausch Health and Bausch + Lomb. Furthermore, the Icahn Group has agreed to waive certain rights from previous agreements. As long as no specified actions are taken, the company will support group nominees for board elections and appointments to new board committees, provided no conflicts of interest arise. Full details of these agreements are available in the attached exhibits.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-123366), on May 21, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10